Please complete the form below to access the on-demand recording of our webinar. A fantastic expert panel of life sciences dealmaking veterans from AstraZeneca and Merck, with 100 years' collective experience, share their insights on key dealmaking strategies, best practices, and common pitfalls to avoid in order to maximise value and mitigate risk in life sciences dealmaking, and also answer audience questions.
Topics discussed include:
- The importance of collaboration as a driver of innovation.
- The current policy landscape and its impact on R&D and investment.
- The dos and don'ts for creating successful transaction agreements.
- Real-world takeaways on dealmaking and integration best practices.
Philip Whitchelo is Sterling's chief strategy & marketing officer.